openPR Logo
Press release

Competent Cells Market Size, Share, Trends, Technology By 2023 Ready to Grow at 51.9%

05-06-2019 08:05 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Meticulous Research®

Competent Cells Market Size, Share, Trends, Technology By 2023

The global competent cells market will grow at a CAGR of 10% from 2018 to 2023 to reach USD 2,318.6 million by 2023, according to this latest publication from Meticulous Research®. The global competent cells market is driven by various factors such as growing demand for recombinant proteins & molecular cloned products, advancement in molecular cloning research with emergence of new technologies, and rising government initiatives and funding for life science research.

Key Opportunities and Challenges for the Competent cells Market
Emerging economies such as Latin America, Asia Pacific, & Africa provides significant opportunities for various stakeholders in this market. However, increasing recombinational and cloning based applications simultaneously enhance the need for maintenance of laboratory transformation parameters; thereby challenging the growth of competent cells market to some extent.

Key Topics Covered in This Report:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Competent Cells Market, by Type
6. Competent Cells Market, by Treatment
7. Competent Cells Market, by Application
8. Competent Cells Market, by End-User
9. Competent Cells Market, by Geography

Browse in-depth Report on :https://www.meticulousresearch.com/product/competent-cells-market-forecast-2023/

Key Market Segments to Watch

The global competent cells market is mainly categorized by type (cloned competent cells, Agrobacterium tumefaciens competent cells, expression competent cells), treatment (chemically competent cells and electrocompetent cells), application (cloning, protein expression, others), end user (pharmaceutical & biotechnology industry, academics & research institutes, and contract research organizations), and geography.

On the basis of type, cloned competent cells commanded the largest share in the global competent cells market in 2017, mainly due to their rising adoption in research with increasing feasibility of genetic therapy, need for rapid diagnosis & treatment, favorable government support for cloning based research in various countries, and rising availability of sophisticated instruments and technology.

On the basis of treatment, chemically competent cells held the largest share in the global competent cells market in 2017. This was mainly attributed to the rising need for cost effective experimental protocol with growing demand for recombinant proteins and molecular cloned products, and rising intensity of cell based research. Chemically competent cells have been commonly used for transformation and vector based molecular cloning experiments because the treatment of competent cells through chemicals is very simple, faster, cost effective, and does not require any specialized equipment.

On the basis of application, cloning accounted for the largest share in the global competent cells market in 2017. The large share of this market is mainly attributed to various advancements in recombinant technology, increasing government support for cloning based research, and rising R&D funding for cell based research.

Based on end user, pharmaceutical and biotechnology industry commanded the largest share in the global competent cells market in 2017, mainly due to higher adoption of competent cells by pharmaceutical & biotechnology companies with growing demand for molecular cloning with advancements in the cloning technologies, and rising investments in research & development to fulfill the demand for protein based therapeutics.

Key players in the global market

The key players in the global competent cells market are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck & Company, Inc., Illumina, Inc., Promega Corporation, New England Biolabs, OriGene Technologies, Inc., Zymo Research Corporation, Scarab Genomics, LLC, Meridian Bioscience, Inc., Delphi Genetics S.A., Qiagen N.V., Cell Applications, Inc., GenScript Biotech Corporation, and Takara Holdings Inc.

Download Sample: https://www.meticulousresearch.com/download-sample-report/?cp_id=3723

Contact Us:
Khushal
Tel: +1-646-781-8004
Email: sales@meticulousresearch.com

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

Asia-Pacific

Office No-202, 203,204,205,206; 2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Competent Cells Market Size, Share, Trends, Technology By 2023 Ready to Grow at 51.9% here

News-ID: 1727701 • Views: 260

More Releases from Meticulous Research®

Radiotherapy Market Worth $10.15 billion by 2025 at a CAGR of 5.6% from 2019 to …
Meticulous Research® – leading global market research company published a research report titled “Radiotherapy Market by Product (Radiotherapy devices, Software, Service), By Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), By Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), By Application (Prostate, Breast) – Global Forecasts to 2025”. Download a Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5023 According to this latest publication from Meticulous Research®, the global radiotherapy market is expected to grow at a CAGR
The Future Of Telehealth | Telemedicine Market : What Covid19 impact does this h …
Meticulous Research® –leading global market research company published a research report titled “Telehealth market/Telemedicine Market by Component (Service, Software, Device), Mode of Delivery (On premise, Web, Cloud), Application (Radiology, Cardiology, Primary/Urgent Care, ICU, Mental Health), End User (Physician, Payor, Patient) — Global Forecast to 2023”. According to this latest publication from Meticulous Research®, the global telehealth market is expected to grow at a CAGR of 23.0% from 2018 to 2023 to
Smart Cities Market Analysis, Post Covid-19 Impact | Potential Business Impacts …
Meticulous Research® — a leading global market research company published a research report titled “Smart Cities Market by Application (Smart Utilities, Smart Transportation, Water Management, Waste Management, Smart Healthcare, Smart Lighting, Smart Education), Component (Hardware, Software, and Services), and Geography- Global Forecast to 2027”. According to this latest publication from Meticulous Research®, the Smart Cities Market is expected to grow at a CAGR of 22.9% from 2019 to reach $545.7 billion
Pre & Post COVID-19 Market Estimates- Ventilators Market Worth $7.72 billion by …
According to a new market research report “Ventilators Market by Product (Instruments, Accessories), Mobility (Intensive Care, Portable), Interface (Invasive, Non-invasive), Age Group (Adult, Pediatric), Mode (Volume, Pressure, Dual), End User (Hospital, ASCs, Home Care) — Global Forecast to 2027”, published by Meticulous Research, the ventilators market is expected to grow at a CAGR of 15.8% from 2020 to reach $7.72 billion by 2027. Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5093 Ventilatory intervention

All 5 Releases


More Releases for Competent

Competent Cells Market Report 2018: Segmentation by Type (Cloned Competent Cells …
Global Competent Cells market research report provides company profile for Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck & Company, Inc., Illumina, Inc., Promega Corporation, New England Biolabs, OriGene Technologies, Inc., Zymo Research Corporation, Scarab Genomics, LLC, Meridian Bioscience, Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to
Healthcare In-Depth Analysis of Competent Cells Market 2018
Competent cells refer to E. coli cells, which comprise altered cell walls to enable assimilation of foreign DNA. Competent cells are broadly used for protein expression and cloning. Advancements in research related to molecular cloning and increasing commercial demand for recombinant proteins and molecular cloned products are some factors impacting growth of the global competent cells market. In its upcoming research report titled “Competent Cells Market: Global Industry Analysis (2012-2016) &
Competent Cells Market Emerging Trends and Growth Analysis Outlook Report
HTF MI presents an in-depth assessment of current Competent Cells key market drivers, market size and trends and North America Competent Cells opportunities, challenges, and restraints as well as key market segments, technological updates, impact of any regulatory policies as well as key market segments. The research study provides forecasts for Competent Cells investments till 2022. If you are involved in the Competent Cells industry or intend to be, then
Global Competent Cells Market Research Report 2017 : Lucigen, Bioline, Genewiz
Qyresearchreports include new market research report "Global Competent Cells Market Research Report 2017" to its huge collection of research reports. This report on the global Competent Cells market is highly detailed, covering all the important aspects of the market. With overwhelming amount of information available on the web about the global Competent Cells market, it becomes impossible to decide what is important and what is not. Expert researchers with much market
Advancements in Global Competent Cells Market: Cloning to Remain Largest Applica …
Researchmoz added Most up-to-date research on "Advancements in Global Competent Cells Market: Cloning to Remain Largest Application of Competent Cells" to its huge collection of research reports. Competent cells refer to E. coli cells, which comprise altered cell walls to enable assimilation of foreign DNA. Competent cells are broadly used for protein expression and cloning. Advancements in research related to molecular cloning and increasing commercial demand for recombinant proteins and molecular
Competent Cells Market Trends, And Forecasts (2016–2021)
The Global Competent Cells Market is worth USD1.3 billion in 2016 and estimated to grow at a CAGR of 10.3%, to reach USD2.12 billion by 2021. The global Competent Cells market is developing at an exceptionally quick pace. View report: http://marketdataforecast.com/market-reports/competent-cells-market-3482/ Transformation is a manner of horizontal gene transfer by which some bacteria take up external genetic material (naked DNA) from the environment. The precondition for microorganisms to undergo transformation is